Electrical storm: A new challenge in the age of implantable defibrillators

Hellenic Journal of Cardiology

Volumn 49, Issue 2, 2008, Pages 86-91

  Gatzoulis, Konstantinos A ^a,c   Sideris, Skevos K ^b   Kallikazaros, Ioannis E ^b   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Electrical storm; Implantable antitachycardiac pacemaker; Implantable defibrillator; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN ANTAGONIST; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; MEXILETINE; PLACEBO; SOTALOL;

CLINICAL FEATURE; DEFIBRILLATOR; FOLLOW UP; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG TERM CARE; PROGNOSIS; RESUSCITATION; REVIEW; UNSPECIFIED SIDE EFFECT;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS; PROGNOSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 43049096806     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Moss AJ, Hall WJ, Cannon DS, et al, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996; 335: 1933-1940.
2. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infraction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
3. Connolly SJ, Hallstrom AP, Cappato R, et al: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21: 2071-2078.
4. DiMarco JP: Implantable cardioverter-defibrillators. N Engl J Med 2003; 349: 1836-1847.
5. Credner SC, Klingenheben T, Maus O, Sticherling C, Hohnloser SH: Electrical storm in patients with transvenous implantable cardioverter defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998; 32: 1909-1915.
6. Greene M, Newman D, Geist M, Heng D, Dorian P: Is electrical storm in ICD patients the sign of a dying heart? Europace 2000; 2; 263-269.
7. Exner DV, Pinski SL, Wyse DG, et al: Antiarrhythmics versus implantable defibrillators. Electrical storm presages non sudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001; 103: 2066-2071.
8. Pinski SL: Emergencies related to implantable cardioverter- defibrillators. Crit Care Med 2000; 28(suppl): N174-N180.
9. Zipes DP, Roberts D; Ftp-c-d investigators: Results of the international study of the implantable pacemaker cardioverter defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995; 92: 59-65.
10. Jordaens LJ, Mekel JM: Electrical storm in the ICD era. Europace 2005; 7: 181-183.
11. Irvine J, Dorian P, Baker B, et al: Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144: 282-289.
12. Gatzoulis KA, Andrikopoulos G, Apostolopoulos T, et al: Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005; 7: 184-192.
13. Brigadeau F, Kouakam C, Klug D, et al: Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006; 27: 700-707.
14. Verma A, Kilicastan F, Marrouche NF, et al: Prevalence predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004; 15: 1265-1270.
15. Stefan H, Hussein R, Craig M, et al, on behalf of the SHock Inhibition Evaluation with azimiLiDe (SHIELD) investigators: Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 2006; 27: 3027-3032.
16. Raitt MH, Klein RC, Whyse DG, et al; Antiarrhythmics versus implantable defibrillators investigators: Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the antiarrhythmics versus implantable defibrillators (AVID) trial. Am J Cardiol 2003; 91: 812-816.
17. Bardy GH, Lee KL, Mark DB, et al: Sudden cardiac death in heart failure trial (SCD-HeFT) investigators: Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
18. Villacastin J, Almendral J, Arenal A: Incidence and clinical significance of multiple consecutive, appropriate, high energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996; 93: 753-762.
19. Arash A, Majid H, Mohammad R, et al: Prevalence and predictors of electrical storm in patients with implantable cardioverter defibrillator. Am J Cardiol 2006; 97: 389-392.
20. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottleb S: Treatment of torsades de pointes with magnesium sulfate. Circulation 1998; 77: 392-397.
21. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE: Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-878.
22. Adhar GC, Swerdlow CD, Lance BL, Clay D, Bardy GH, Greene HL: Tocainide for drug-resistant sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1988; 11: 124-131.
23. Burjorjee JE, Milne B: Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anesth 2002; 49: 973-977.
24. Connoly ST, Dorian P, Roberts RS, Gent M, Bailin S, Fuin ES: Comparison of b-blockers, amiodarone plus b-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the Optic study: a randomized trial. JAMA 2006; 295: 165-171.
25. Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tafia DS; Shock inhibition evaluation with azimilide (SHIELD) investigators: Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004; 110: 3646-3654.
26. Stevenson WG: Catheter ablation of monomorphic ventricular tachycardia. Curr Opin Cardiol 2005; 20: 42-47.
27. Szumowski L, Sanders P, Walczak F, Hocini M, Jais P, Kepski R: Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2004; 44: 1700-1706.
28. Gatzoulis KA, Ioannidis P, Vasilopoulos HV: Electrical storm in a patient with dilated cardiomyopathy 11 years after defibrillator implantation. The role of intracardiac catheter ablation. Cardiology Update 2006. Nosokomeiaka Hronika 2006 (suppl): 58-61.
29. Kolettis TM, Naka KK, Katsouras CS: Radiofrequency catheter ablation for electrical storm in a patient with dilated cardiomyopathy. Hellenic J Cardiol 2005; 46: 366-369.
30. Gatzoulis KA, Gialafos IE: Dual chamber antitachycardia cardioverter defibrillators. Another step for the treatment of high risk patients. Hellenic J Cardiol 2003; 44: 71-79.
31. Katsouras GE, Margos PN, Livanis EG, Theodorakis GN, Kremastinos DT: Contribution of electroanatomical mapping to the diagnosis of arrhythmogenic right ventricular cardiomyopathy in a patient with sustained ventricular tachycardia. Hellenic J Cardiol 2006; 47: 184-189.
32. O'Rourke RA: Role of myocardial revascularization in sudden cardiac death. Circulation 1992; 85: 112-117.
33. Hunt AS: 24th Bethesda conference: Cardiac transplantation. J Am Coll Cardiol 1993; 22: 1-64.
34. Cazeau S, Leclercq C, Lavergne T, et al; for the MUSTIC study investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880.